Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Control Bionics Ltd. ( (AU:CBL) ) has shared an update.
Control Bionics Limited reported a 2.3% decrease in revenues from ordinary activities for the half-year ended December 31, 2024, totaling $2,896,291. The company also experienced a significant increase in its loss from ordinary activities after tax, which rose by 47.12% to $3,222,197. No dividends were declared during this period. The financial results indicate challenges in improving profitability, which may impact the company’s strategic initiatives and stakeholder confidence.
More about Control Bionics Ltd.
Control Bionics Limited operates in the technology sector, focusing on developing innovative assistive communication devices. The company primarily provides products that enable individuals with disabilities to communicate and interact with their environment, catering to a niche market that requires specialized technological solutions.
YTD Price Performance: -30.0%
Average Trading Volume: 136,979
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$10.58M
See more insights into CBL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue